IBD: Mucosal healing - EXTENDing our knowledge in Crohn's disease

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 6, 2012, Pages 309-311

  Danese, Silvio ^a   Peyrin Biroulet, Laurent ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; PLACEBO;

COLONOSCOPY; CROHN DISEASE; DISEASE DURATION; ENDOSCOPY; HUMAN; ILEOCOLONOSCOPY; INTESTINE ULCER; MAINTENANCE THERAPY; MUCOSAL HEALING; PRIORITY JOURNAL; REMISSION; SHORT SURVEY; ULCER HEALING;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; CROHN DISEASE; HUMANS; INTESTINAL MUCOSA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 84861973602     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.77     Document Type: Short Survey

References (10)

1. Fiorino, G. et al. Adalimumab in Crohn's disease: tips and tricks after 5 years of clinical experience. Curr. Med. Chem. 18, 1230-1238 (2011).
2. nd Scientific Workshop of the ECCO. I: impact of mucosal healing on the course of inflammatory bowel disease. J. Crohns Colitis 5, 477-483 (2011).
3. Rutgeerts, P. et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology http://dx.doi.org/10.1053/j.gastro.2012.01.035.
4. Pineton de Chambrun, G., Peyrin-Biroulet, L., Lémann, M. & Colombel, J. F. Clinical implications of mucosal healing for the management of IBD. Nat. Rev. Gastroenterol. Hepatol. 7, 15-29 (2010).
5. Colombel, J. F. et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N. Engl. J. Med. 362, 1383-1395 (2010).
6. Colombel, J. F. et al. S1045 endoscopic mucosal improvement in patients with active Crohn's disease treated with certolizumab pegol: week 10 and 54 results of the MUSIC trial. Gastroenterology 138 (Suppl. 1), S166 (2010).
7. Peyrin-Biroulet, L. et al. Development of the Paris definition of early Crohn's disease for disease. Modification trials: results of an International Consensus. Am. J. Gastroenterol. (in press).
8. D'Haens, G. et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm. Bowel Dis. http://dx.doi.org/10.1002/ibd.22917.
9. Fiorino, G., Bonifacio, C., Malesci, A., Balzarini, L. & Danese, S. MRI in Crohn's disease - current and future clinical applications. Nat. Rev. Gastroenterol. Hepatol. 9, 23-31 (2011).
10. Pariente, B. et al. Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm. Bowel Dis. 17, 1415-1422 (2011).